The Diabetes Research Group (DRG) work directly with patients with Type 1, Type 2 and Gestational Diabetes, utilising state of the art technologies to provide novel and more effective therapeutic interventions.
PhD Students at University of Brighton
Karen Sargent
CGMS technology for improved outcomes in patients with gestational diabetes.
Victoria Ordor
Continuous Glucose Monitoring Systems (CGMS) as a motivational tool in young obese individuals. PhD sponsored by the Niger Delta Development Commission.
Elaine Sharp
Investigating the role of psychological time perspective in adherence to self-care in young adults with type 1 diabetes mellitus (T1D)
Madeline Honey
The effect of anti-psychotic drugs on long-term beta-cell survival and pancreatic function.
Alice Hagan
Elucidation of the Mechanism of Action of Locally-delivered Novel Chemotherapeutic Agent Combinations from Drug-eluting Embolisation Systems. PhD sponsored by an 1851 Royal Commission Fellowship in collaboration with BTG. PhD Awarded 2018
Dr Nouf Alhasawi
Protection of islet cells for transplantation therapy in type 1 diabetes. PhD awarded 2016
Dr Ben McCutcheon
Mining bugs for drugs: Discovery and characterization of novel bioactive compounds from the human gut microbiome. PhD awarded 2016.
Dr Sandeep Kumar
Expression, subcellular localisation and regulation of programmed cell death gene 4 (PDCD4) in human pancreatic cells in response to hypoxia. PhD awarded 2015.
Dr Jonathan Nzakizwanayo
Investigation of host-microbe interactions in the probiotics. PhD Awarded 2014.